Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Board of Directors
Share |

 

Executive Committee

  • Martin Simonetti | CEO, MASx2 Consulting (Chair) 
  • Leslie Alexandre | DrPH, President & CEO, Life Science Washington (Secretary) 
  • Caitlin Cameron | CEO, OtoNexus Medical Technologies (Vice Chair)
  • Lisa Cohen
  • Ralph Derrickson | CEO, Carena
  • Stephen M. Graham | Partner, Fenwick & West LLP
  • Brad Gray | President & CEO, NanoString Technologies, Inc.
  • Oren Lang-Furr | Partner, EY
  • Thong Q. Le | CEO, Accelerator Corporation 
  • Margaret McCormick, PhD  CEO, Matrix Genetics (Treasurer)
  • Erik Nilsson  | CEO, Deurion, LLC 
  • Gregory Sessler | President & CEO, Olympus Respiratory America
  • Francisco R. Velázquez | MD

 

Board of Directors

  • Susan Ashe | Executive Director Health Sciences & Services Authority
  • Charles V. Baltic III | Managing Director & Co-Head of Life Sciences, Needham & Company, LLC
  • Jan Beck |  VP & Site Head, Novo Nordisk
  • Nicole Bell | Executive Director, Cambia Grove
  • Bill Brady | President, Brady & Company
  • Thomas Clement | President & CEO, Aqueduct Critical Care
  • John Cox |  SVP-Seattle, Alexandria Real Estate Equities, Inc.
  • Helga Ding, DDS | Managing Director, Kaiser Permanente Research Institute
  • Sonya F. Erickson |  Partner, Cooley LLP
  • Teresa Foy, PhD |  Senior Director, Celgene
  • James B. Hendricks, PhD | President, Seattle Children’s Research Institute
  • Charlotte Hubbert, PhD, | Partner - Gates Foundation Venture Capital, Bill & Melinda Gates Foundation
  • Leen Kawas, PharmD & PhD |  President & CEO, M3 Biotechnology
  • Jary J. Krauser | CEO, StratusG Consulting
  • Homer Lane |  Executive Director & CFO, Benaroya Research Institute
  • Gustavo Mahler | PhD, President & Global COO, CMC Biologics
  • Tim Martin | Director of Global Government Affairs, Amgen
  • Ron Myers | CEO, Nexgenia Inc. 
  • Robert W. Overell, PhD |  President & CEO, PhaseRx, Inc.
  • Craig W. Philips | COO, KPI Therapeutics
  • Jens U. Quistgaard, PhD | Chairman,  Mirabilis Medica
  • Rhonda Rhyne | President & CEO, Prevencio, Inc. 
  • Ken Roberts, PhD | Vice Dean of Academic and Community Partnerships, Elson S. Floyd College of Medicine, Washington State University 
  • Chad Robins | CEO, Adaptive Biotechnologies 
  • Mike Ruhl | Vice President, Seattle Market Lead, BioMed Realty & Trust
  • Randy Schatzman | CEO, Alder BioPharmaceuticals, Inc.
  • R. Lee Schindler |  Partner, Perkins Coie LLP 
  • Andrew T. Serafini | PhD, Partner, Kilpatrick Townsend & Stockton LLP
  • Todd Simpson | CFO, Seattle Genetics, Inc.
  • Ken Stuart, PhD | President & Professor, Center for Infectious Disease Research
  • Matt Stupfel | General Manager, EKOS Corporation
  • John Wecker, PhD |  President & CEO, Pacific Northwest Diabetes Research Institute

 

more Calendar

9/26/2017
2017 LSW Program: Cancer Immunotherapy

10/3/2017
Student Career Development Workshop

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal